Publications

  1. Mahale P, Shiels MS, Lynch CF, Engels EA. Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients. Am J Transplant. 2017 Aug 14.
  2. Yanik EL, Shiels MS, Smith JM, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA. Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States. Cancer. 2017 Jul 31.
  3. Zamoiski RD, Yanik E, Gibson TM, Cahoon EK, Madeleine MM, Lynch CF, Gustafson S, Goodman MT, Skeans M, Israni AK, Engels EA, Morton LM. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers. Cancer Res. 2017 Aug 1;77(15):4196-4203.
  4. Yanik EL, Smith JM, Shiels MS, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA. Cancer Risk After Pediatric Solid Organ Transplantation. Pediatrics. 2017 May;139(5).
  5. Kitahara CM, Yanik EL, Ladenson PW, Hernandez BY, Lynch CF, Pawlish KS, Engels EA. Risk of Thyroid Cancer Among Solid Organ Transplant Recipients. Am J Transplant. 2017 Apr 11.
  6. Hussain SK, Makgoeng SB, Everly MJ, Goodman MT, Martínez-Maza O, Morton LM, Clarke CA, Lynch CF, Snyder J, Israni A, Kasiske BL, Engels EA. HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation. Transplantation. 2016 Nov;100(11):2453-2460.
  7. Fink AK, Yanik EL, Marshall BC, Wilschanski M, Lynch CF, Austin AA, Copeland G, Safaeian M, Engels EA. Cancer risk among lung transplant recipients with cystic fibrosis. J Cyst Fibros. 2016 Aug 15. pii: S1569-1993(16)30568-9. doi: 10.1016/j.jcf.2016.07.011.
  8. Karami S, Yanik EL, Moore LE, Pfeiffer RM, Copeland G, Gonsalves L, Hernandez BY, Lynch CF, Pawlish K, Engels EA. Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States. Am J Transplant. 2016 May 10. doi: 10.1111/ajt.13862.
  9. Yanik EL, Nogueira LM, Koch L, Copeland G, Lynch CF, Pawlish KS, Finch JL, Kahn AR, Hernandez BY, Segev DL, Pfeiffer RM, Snyder JJ, Kasiske BL, Engels EA. Comparison of cancer diagnoses between the US solid organ transplant registry and linked central cancer registries. Am J Transplant. 2016 Apr 7. doi: 10.1111/ajt.13818
  10. Arron ST, Raymond AK, Yanik EL, Castenson D, McCulloch CE, Clarke CA, Paddock LE, Niu X, Engels EA. Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma. Dermatol Surg. 2016 Feb;42(2):157-66. doi: 10.1097/DSS.0000000000000602.
  11. Safaeian M, Robbins HA, Berndt SI, Lynch CF, Fraumeni JF Jr, Engels EA. Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. Am J Transplant. 2016 Mar;16(3):960-7. doi: 10.1111/ajt.13549.
  12. Yanik EL, Clarke CA, Snyder JJ, Pfeiffer RM, Engels EA. Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals. J Am Soc Nephrol. 2016 May;27(5):1495-504. doi: 10.1681/ASN.2015040373.
  13. Robbins HA, Clarke CA, Arron ST, Tatalovich Z, Kahn AR, Hernandez BY, Paddock L, Yanik EL, Lynch CF, Kasiske BL, Snyder J, Engels EA. Melanoma Risk and Survival among Organ Transplant Recipients. J Invest Dermatol. 2015 Nov;135(11):2657-65. doi: 10.1038/jid.2015.312.
  14. Kalil RS, Lynch CF, Engels EA. Risk of cancer in retransplants compared to primary kidney transplants in the United States. Clin Transplant. 2015 Oct;29(10):944-50. doi: 10.1111/ctr.12601.
  15. Shiels MS, Copeland G, Goodman MT, Harrell J, Lynch CF, Pawlish K, Pfeiffer RM, Engels EA. Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients. Cancer. 2015 Jun 15;121(12):2063-71. doi: 10.1002/cncr.29324.
  16. Clarke CA, Robbins HA, Tatalovich Z, Lynch CF, Pawlish KS, Finch JL, Hernandez BY, Fraumeni JF Jr, Madeleine MM, Engels EA. Risk of merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst. 2015 Jan 8;107(2). pii: dju382. doi: 10.1093/jnci/dju382.
  17. Yanik EL, Gustafson SK, Kasiske BL, Israni AK, Snyder JJ, Hess GP, Engels EA, Segev DL. Sirolimus use and cancer incidence among US kidney transplant recipients. Am J Transplant. 2015 Jan;15(1):129-36. doi: 10.1111/ajt.12969.
  18. Hall EC, Engels EA, Pfeiffer RM, Segev DL. Association of antibody induction immunosuppression with cancer after kidney transplantation. Transplantation. 2015 May;99(5):1051-7. doi: 10.1097/TP.0000000000000449.
  19. Morton LM, Gibson TM, Clarke CA, Lynch CF, Anderson LA, Pfeiffer R, Landgren O, Weisenburger DD, Engels EA. Risk of myeloid neoplasms after solid organ transplantation. Leukemia. 2014 Dec;28(12):2317-23.
  20. Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL, Engels EA. Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol. 2014 Oct;25(10):2335-41.
  21. Koshiol J, Pawlish K, Goodman MT, McGlynn KA, Engels EA. Risk of hepatobiliary cancer after solid organ transplant in the United States. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1541-9.
  22. Gibson TM, Engels EA, Clarke CA, Lynch CF, Weisenburger DD, Morton LM. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol. 2014 Jul;89(7):714-20.
  23. Engels EA, Castenson D, Pfeiffer RM, Kahn A, Pawlish K, Goodman MT, Nalesnik MA, Israni AK, Snyder J, Kasiske B. Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses. Am J Transplant. 2014 Jun;14(6):1376-82.
  24. Morton LM, Gibson TM, Clarke CA, Lynch CF, Weisenburger DD, Engels EA. Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients. Haematologica. 2014 May;99(5):70-3.
  25. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant. 2013 Dec;13(12):3202-9.
  26. Hall EC, Engels EA, Montgomery RA, Segev DL. Cancer risk after ABO-incompatible living-donor kidney transplantation. Transplantation. 2013 Sep 15;96(5):476-9.
  27. Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer. 2013 Jul 9;109(1):280-8.
  28. Engels EA, Clarke CA, Pfeiffer RM, Lynch CF, Weisenburger DD, Gibson TM, Landgren O, Morton LM. Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant. 2013 Jun;13(6):1523-32.
  29. Hall EC, Pfeiffer RM, Segev DL, Engels EA. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013 Jun 15;119(12):2300-8.
  30. Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD, Lynch CF, Goodman MT, Engels EA. Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am J Hematol. 2013 Apr;88(4):245-50.
  31. Hall EC, Segev DL, Engels EA. Racial/ethnic differences in cancer risk after kidney transplantation. Am J Transplant. 2013 Mar;13(3):714-20.
  32. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011 Nov 2;306(17):1891-901.